Opus Health, VoicePort to develop joint pharmacy solution
BEDMINSTER, N.J., and ROCHESTER, N.Y. — A co-marketing agreement has been inked between Cegedim Relationship Management’s Opus Health division and VoicePort.
The companies said that they will create a joint, pharmacy-focused solution that will be designed to improve prescription compliance and offer patient co-pay assistance. Through this agreement, Opus Health and VoicePort will provide advanced marketing solutions to keep pharmacies in contact with patients by leveraging VoicePort’s PharmaPhonetics — an advanced self-service technology using speech recognition to automate interactions — and Opus Health’s co-pay assistance and medication adherence programs, to extend patient reach by establishing lasting dialogues and offering patients co-pay assistance intended to increase medication adherence.
“Solutions to increase medication adherence are in great need as patient noncompliance drains an estimated $300 billion dollars a year from the U.S. healthcare system,” VoicePort president and CEO Christopher Mann said. “This joint solution will help us collaborate with key retailers throughout the [United States] who focus on improved patient outcomes by leveraging the latest in communication technology.”
Added Mark Calabrese, VP and general manager of Opus Health for Cegedim Relationship Management, "Through our partnership with VoicePort, we aim to improve patient care and make brand medication more affordable by working directly with pharmacies. Pharmacies have direct and regular contact with patients, so they are in a position to promote adherence. Our joint solution builds on our IVR pharmacy network and enables this, and in so doing, benefits the pharmacy, as well by helping them increase customer satisfaction and, therefore, market share."
Bartell offers flu vaccines
SEATTLE — Regional retail pharmacy chain Bartell Drugs has launched its flu vaccination campaign, the Seattle-based company said Tuesday.
Bartell said it would offer a full schedule of in-store vaccinations for individuals on a walk-in basis and a program servicing area businesses. The "in-the-workplace" vaccination program, now in its fifth year, serves businesses with 25 or more employees.
In addition to regular vaccines, the chain is offering Sanofi Pasteur’s Fluzone High-Dose vaccine designed for patients 65 and older.
Editorial questions study on atmospheric pressure’s influence on insulin pump devices
NEW ROCHELLE, N.Y. — More evidence may be needed to support research that implied that atmospheric pressure during airplane travel could influence the effectiveness of insulin pump devices, according to an editorial published in Diabetes Technology & Therapeutics.
Irl Hirsch, senior editor of the peer-reviewed journal and professor of medicine at University of Washington School of Medicine (Seattle), commented on a recent study — "Changes in altitude cause unintended insulin delivery from insulin pumps: mechanisms and implications" — that claimed changes in atmospheric pressure in a hypobaric chamber caused the improper amounts of insulin were delivered to a small number of patients with Type 1 diabetes who used insulin pumps. Hirsch said that the research had several limitations.
"This study was implemented in such a small number of people that large conclusions may not be justified," Hirsch wrote. "It is possible the authors overreacted in their recommendations."